论文部分内容阅读
目的:对肿瘤标志物CA125与CEA在妇科肿瘤诊治中的临床价值进行探讨与分析。方法:根据相关案例进行回顾性分析,某院自2007年1月至2010年3月期间收治了64例妇科肿瘤患者,其中有26例是恶性肿瘤患者,有38例是良性肿瘤患者。该院将这26例恶性肿瘤患者作为观察组,将38例良性肿瘤患者作为对照组,并对两组患者术前与术后的CA125与CEA进行了相关的检测与对比。结果:该院对照组与观察组的CA125值分别是(41.8±55.1)Unit/ml与(248.8±187.1)Unit/ml,且两组术后的CA125值均有所下降;另外,两组CEA在术前术后的差异并不显著,而总的趋势则是术后低于术前,且阳性检出率为20%;血清CA125的阳性检出率是75%,且在与CEA结合后升至80.0%左右。结论:在诊治妇科肿瘤的过程中,血清CA125与CEA联合检测可以有效辨别良恶性肿瘤,为患者的早期诊断提供相对有效的依据。
Objective: To explore and analyze the clinical value of tumor markers CA125 and CEA in gynecologic oncology. Methods: According to the related cases, we retrospectively analyzed 64 cases of gynecological tumors from January 2007 to March 2010 in our hospital, of which 26 cases were malignant tumors and 38 cases were benign tumors. The hospital will be 26 cases of malignant tumor patients as observation group, 38 cases of benign tumor patients as a control group, and the two groups of patients before and after the CA125 and CEA were detected and compared. Results: The CA125 values of the control group and the observation group were (41.8 ± 55.1) Unit / ml and (248.8 ± 187.1) Unit / ml, respectively, and both the values of CA125 decreased after operation. In addition, The preoperative and postoperative differences were not significant, but the overall trend was postoperatively less than preoperative, and the positive detection rate was 20%; the positive detection rate of serum CA125 was 75%, and in combination with CEA Rose to 80.0% or so. Conclusion: In the diagnosis and treatment of gynecologic oncology, the combined detection of serum CA125 and CEA can effectively differentiate benign and malignant tumors and provide a relatively effective basis for the early diagnosis of patients.